• Explore /
  • Poster
  • / Safety and efficacy of MEDI4736, an anti-PD-L1 antibody, in patients from a squamous cell carcinoma of the head and neck (SCCHN) expansion cohort.

Safety and efficacy of MEDI4736, an anti-PD-L1 antibody, in patients from a squamous cell carcinoma of the head and neck (SCCHN) expansion cohort.

Abstract Poster

Authors

null

Neil Howard Segal

Memorial Sloan Kettering Cancer Center, New York, NY

Neil Howard Segal , Sai-Hong Ignatius Ou , Ani Sarkis Balmanoukian , Matthew G. Fury , Erminia Massarelli , Julie R. Brahmer , Jared Weiss , Patrick Schoffski , Scott Joseph Antonia , Christophe Massard , Dan Paul Zandberg , Samir Khleif , Xia Li , Marlon Rebelatto , Keith Steele , Paul B. Robbins , John A. Blake-Haskins , Marcus O. Butler

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research

Sub Track

Immunotherapy and Biologic Therapy

Clinical Trial Registration Number

NCT01693562

Citation

J Clin Oncol 33, 2015 (suppl; abstr 3011)

DOI

10.1200/jco.2015.33.15_suppl.3011

Abstract #

3011

Poster Bd #

337

Abstract Disclosures

Similar Posters

First Author: Lillian L. Siu

First Author: Naiyer A. Rizvi

First Author: Charu Aggarwal

First Author: Tanguy Y. Seiwert